1. PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade;Hirsch;Br J Cancer,2019
2. Les cancers en France en 2013, Collection état des lieux et des connaissances, ouvrage collectif édité par l’INCa, Boulogne-Billancourt,2014
3. Dying with cancer: the influence of age, comorbidity, and cancer site;Kendal;Cancer,2008
4. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015
5. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease;Nagele;PloS One,2013